Cancer Biotech TetraLogic Pharmaceuticals Files for a $104 Million IPO

Published: Oct 21, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TetraLogic Pharmaceuticals, which is developing small molecule therapeutics for the treatment of cancer, filed on Friday with the SEC to raise up to $104 million in an initial public offering. The Malvern, PA-based company, which was founded in 2001, plans to list on the NASDAQ under the symbol TLOG.

Help employers find you! Check out all the jobs and post your resume.

Back to news